Upadacitinib Is Effective for the Induction and Maintenance of

Evidence-Based GI: An ACG Publication and Podcast

Upadacitinib Is Effective for the Induction and Maintenance of Moderate-to-Severe Crohn’s Disease

Listen now

Description

Rahul Dalal, MD, MPH and Jessica Allegretti, MD, MPH discuss “Upadacitinib Induction and Maintenance Therapy for Crohn's Disease,” by Loftus EV Jr, Panés J, Lacerda AP, Peyrin-Biroulet L, et al. N Engl J Med [2023 May 25;388(21):1966-1980].

More Episodes

See all »

PROFILE: Can Molecular Biomarkers Predict Outcomes to Crohn’s Disease Treatment?

Philip Schoenfeld, MD, MSEd, MSc (Epi) and Bharati Kochar, MD, MS discuss “A biomarker-stratified comparison of top-down versus accelerated step-up treatment strategies for patients with newly diagnosed Crohn’s disease (PROFILE): a multicentre, open-label randomised controlled trial,” by Noor NM...

Published 05/15/24

Multi-Target Stool DNA Test for CRC Screening: How Accurate is the New Version?

Philip Schoenfeld, MD, MSEd, MSc (Epi) and Jacqueline Gaulin discuss “Next-generation multitarget stool DNA test for colorectal cancer screening,” by T, Porter K, Zella J, et al. N Engl J Med. 2024; 390: 984-93.

Published 05/15/24

Linaclotide Effective for Functional Constipation in 6-17 Year Olds: First FDA-Approved Constipation Treatment for Children

Philip Schoenfeld, MD, MSEd, MSc (Epi) and Ahmad Abu-Heija, MBBS discuss “Efficacy and safety of linaclotide in treating functional constipation in paediatric patients: a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial,” by Di Lorenzo C, Khlevner J, Rodriguez-Araujo G, et...

Published 05/15/24